# Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial

Article · Christopher Paul Cannon, Bertrand Cariou, Dirk Jacobus Blom, James M. McKenney, Christelle Lorenzato, Robert C. Pordy, Umesh Chaudhari, Helen Martina Colhoun

- Archive id: doi:10.1093/eurheartj/ehv028
- Published: 2015-02-16
- Venue: European Heart Journal
- DOI: https://doi.org/10.1093/eurheartj/ehv028
- PMID: 25687353
- Citations: 400
- Source URL: https://doi.org/10.1093/eurheartj/ehv028
- PDF: https://academic.oup.com/eurheartj/article-pdf/36/19/1186/17355154/ehv028.pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cardiovascular Therapeutics](https://space-kitty.com/topics/cardiovascular-innovation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.